Hunan Jingfeng Pharmaceutical Hits Day Low Amid Price Pressure at CNY 6.81

Hunan Jingfeng Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.08% as it reached an intraday low of CNY 6.81. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 1.7% during the same period. Over the past week, Hunan Jingfeng has seen a decrease of 4.89%, while its monthly performance reflects a decline of 5.68%. Year-to-date, the stock has lost 5.29%, although it has shown a positive annual return of 21.39%, outperforming the China Shanghai Composite's 16.95% gain. Financial metrics indicate that the company is facing challenges, with a net profit of CNY -32.65 million reflecting a significant decline of 113.17%. Additionally, the operating cash flow has reached a low of CNY -23.68 million. The stock's risk profile is heightened, trading at valuations that are considered risky compared to historical averages. Despite a three-year performance increase of 152.22%, the stock's long-term trajectory shows a decline of 42.92% over the past decade.